Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
Open Access
- 16 November 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (11) , e7850
Abstract
MiRNAs regulate gene expression at a post-transcriptional level and their dysregulation can play major roles in the pathogenesis of many different forms of cancer, including neuroblastoma, an often fatal paediatric cancer originating from precursor cells of the sympathetic nervous system. We have analyzed a set of neuroblastoma (n = 145) that is broadly representative of the genetic subtypes of this disease for miRNA expression (430 loci by stem-loop RT qPCR) and for DNA copy number alterations (array CGH) to assess miRNA involvement in disease pathogenesis. The tumors were stratified and then randomly split into a training set (n = 96) and a validation set (n = 49) for data analysis. Thirty-seven miRNAs were significantly over- or under-expressed in MYCN amplified tumors relative to MYCN single copy tumors, indicating a potential role for the MYCN transcription factor in either the direct or indirect dysregulation of these loci. In addition, we also determined that there was a highly significant correlation between miRNA expression levels and DNA copy number, indicating a role for large-scale genomic imbalances in the dysregulation of miRNA expression. In order to directly assess whether miRNA expression was predictive of clinical outcome, we used the Random Forest classifier to identify miRNAs that were most significantly associated with poor overall patient survival and developed a 15 miRNA signature that was predictive of overall survival with 72.7% sensitivity and 86.5% specificity in the validation set of tumors. We conclude that there is widespread dysregulation of miRNA expression in neuroblastoma tumors caused by both over-expression of the MYCN transcription factor and by large-scale chromosomal imbalances. MiRNA expression patterns are also predicative of clinical outcome, highlighting the potential for miRNA mediated diagnostics and therapeutics.Keywords
This publication has 25 references indexed in Scilit:
- microRNA Profiling Identifies Cancer-Specific and Prognostic Signatures in Pediatric MalignanciesClinical Cancer Research, 2009
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid TumorsCancer Research, 2009
- A novel and universal method for microRNA RT-qPCR data normalizationGenome Biology, 2009
- High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNANucleic Acids Research, 2008
- The MYCN oncogene is a direct target of miR-34aOncogene, 2008
- Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIMPLOS ONE, 2008
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerProceedings of the National Academy of Sciences, 2008
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cellsOncogene, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006